Keytruda (Pembrolizumab) is an FDA approved humanized antibody used in cancer immunotherapy. This includes treating melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer. It is given by slow injection into a vein.

keytruda is not chemotherapy or radiation therapy—it is an immunotherapy and it works with your immune system to help fight certain cancers.

keytruda can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. These problems may happen anytime during treatment or even after your treatment has ended.

Find the Keytruda Package Insert in PDF below

[pdf-embedder url=”https://www.publichealth.com.ng/wp-content/uploads/2021/01/Keytruda-Package-Insert.pdf” title=”Keytruda Package Insert”]